Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Journey Medical (DERM) over the last 4 years, with Dec 2024 value amounting to $20.4 million.

  • Journey Medical's Shares Outstanding (Diluted Average) rose 21.53% to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 21.53%. This contributed to the annual value of $20.4 million for FY2024, which is 12.06% up from last year.
  • Per Journey Medical's latest filing, its Shares Outstanding (Diluted Average) stood at $20.4 million for FY2024, which was up 12.06% from $18.2 million recorded in FY2023.
  • Journey Medical's Shares Outstanding (Diluted Average)'s 5-year high stood at $20.4 million during FY2024, with a 5-year trough of $10.2 million in FY2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $18.7 million, with a median of $18.2 million in 2023.
  • Data for Journey Medical's Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 72.05% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Journey Medical's Shares Outstanding (Diluted Average) stood at $10.2 million in 2021, then skyrocketed by 72.05% to $17.5 million in 2022, then rose by 4.00% to $18.2 million in 2023, then increased by 12.06% to $20.4 million in 2024.